[account_shop_links]
Gilead Sciences Clinical Development Profile
$700.00 – $1,400.00
Licensing Options
- SINGLE-USER LICENSE
A Single-User License allows access to an individual user.
- ENTERPRISE-WIDE LICENSE
An Enterprise-Wide License allows access to all employees and sites within an organization.
Report Overview
With a market capitalization greater than $100B, Gilead is fast becoming one of the most influential pharmaceutical companies in the world. ISR’s report provides a thorough analysis of Gilead Sciences’ R&D pipeline, clinical trial activity, patents, FDA submissions, and includes profiles of Gilead’s key products.
How you can use this report:
- Pharmaceutical Companies: Identify the clinical and commercial status of competing compounds and understand how these will affect the launch of similar/ competing products.
- Service Providers: Better prepare your business development activities focused on Gilead. Understand their strategic direction, current and potential clinical development pipeline, and historic trial metrics.
Report Contents:
1. Background and Strategy
- Financial Condition
- Drug Sales
- Stock Performance
2. Research and Development
- Development Pipeline Overview
3. Clinical Trial Activity
- Number of Clinical Trials
- Length of Clinical Trials
- Projected vs. Actual On-Going Trial Length
- Enrollment in Clinical Trials
4. Patents
5. FDA Submissions
6. Key Product Profiles
7. Summary
- R&D Spending
- Clinical Development Summary
- Key Compound and MOA Overview
